Momentum 25mg IV Inj. 1`s (Etanercept)

Each vial contains 25mg of etanercept, a tumor necrosis factor blocker manufactured by Macter International in Pakistan. Buy Momentum 25mg Injection online at PakMeds for authentic supply and nationwide delivery.

Momentum 25mg Injection Ingredients and Usage

Momentum 25mg Injection contains etanercept, a biologic drug in the tumor necrosis factor (TNF) alpha blocker class. Doctors prescribe it for moderate to severe rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, active psoriatic arthritis, ankylosing spondylitis, and chronic plaque psoriasis. The medicine comes as a sterile lyophilized powder that requires reconstitution before subcutaneous injection.

Rheumatology specialists in Pakistan use Momentum 25mg Injection for patients whose disease does not respond to standard disease modifying antirheumatic drugs (DMARDs). Etanercept is given alone or with methotrexate to reduce joint pain, stiffness, and swelling. Long term therapy can also slow the progression of joint damage in inflammatory arthritis.

How Does Momentum 25mg Injection Work?

Momentum 25mg Injection works by binding to tumor necrosis factor alpha (TNF-alpha), a cytokine that drives inflammation in autoimmune disease. Etanercept is a dimeric fusion protein made from the human p75 TNF receptor linked to the Fc portion of human IgG1. This structure lets etanercept intercept both TNF-alpha and TNF-beta before they reach cell surface receptors.

By blocking TNF signalling, Momentum 25mg Injection reduces inflammatory activity in the joints, skin, and spine. The clinical response typically appears within 1 to 2 weeks of starting therapy and reaches a plateau by 3 months. Etanercept does not permanently deplete immune cells, so its immunosuppressive effect is reversible after treatment stops.

Momentum 25mg Injection Side Effects

Momentum 25mg Injection can cause injection site reactions and systemic side effects during treatment. Most reactions are mild, but patients should watch for signs of infection, unusual bleeding, or worsening breathing.

• Injection site redness, itching, pain, or swelling

• Upper respiratory tract infections and sinusitis

• Headache and dizziness

• Nausea, abdominal pain, and vomiting

• Rhinitis and sore throat

• Fatigue and low grade fever

• Skin rash and pruritus

Warnings

• Increased risk of serious bacterial, viral, and fungal infections, including tuberculosis reactivation.

• Screen for latent tuberculosis and hepatitis B before starting Momentum 25mg Injection.

• Not recommended in patients with active severe infections or sepsis.

• Contraindicated in moderate to severe congestive heart failure (NYHA class III or IV).

• Live vaccines should not be given during etanercept therapy.

• Rare reports of demyelinating disorders such as multiple sclerosis and optic neuritis.

• Increased risk of lymphoma and other malignancies, especially in children and adolescents.

• Do not combine with other biologic DMARDs such as anakinra or abatacept.

• Discuss risks and benefits with a specialist before use in pregnancy or breastfeeding.

Momentum 25mg Injection Storage Conditions

Store Momentum 25mg Injection in a refrigerator between 2 and 8 degrees Celsius, and never freeze the vial. Keep the packaging in its original carton to protect the etanercept powder from light and humidity. Always keep the injection out of reach of children, and never use a vial past its printed expiry date.